Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -18.90% is in line with its 5-year average of -20.03%, near the high end of its 5-year range (-44.71%–-8.97%).
As of the fiscal period ended Tuesday, June 30, 2026. 32.72% above its 12-month average of -28.09%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -18.90%.
RETURN ON INVESTED CAPITAL (ROIC)
-18.90%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-28.09%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-27.96%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-20.03%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+32.72%
CURRENT VS 3Y AVG
+32.40%
CURRENT VS 5Y AVG
+5.64%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.53%
median of 569 covered companies
CURRENT VS SECTOR MEDIAN
+41.90%
vs the sector median at left
908 Devices Inc.
Market Cap
$513.25M
Return on Invested Capital (ROIC)
-18.90%
TTM Avg
-28.09%
3Y Avg
-27.96%
5Y Avg
-20.03%
Market Cap
$507.55M
Return on Invested Capital (ROIC)
-16.89%
TTM Avg
-20.74%
3Y Avg
-75.97%
5Y Avg
-65.59%
Market Cap
$516.46M
Return on Invested Capital (ROIC)
-19.47%
TTM Avg
-57.88%
3Y Avg
-52.57%
5Y Avg
-47.02%
Market Cap
$521.76M
Return on Invested Capital (ROIC)
-18.20%
TTM Avg
-95.31%
3Y Avg
-87.63%
5Y Avg
-71.60%
Market Cap
$498.75M
Return on Invested Capital (ROIC)
-34.79%
TTM Avg
-53.61%
3Y Avg
-51.25%
5Y Avg
-40.96%
Market Cap
$531.34M
Return on Invested Capital (ROIC)
-102.59%
TTM Avg
-133.31%
3Y Avg
-119.78%
5Y Avg
-99.25%
Market Cap
$533.01M
Return on Invested Capital (ROIC)
-0.81%
TTM Avg
-8.59%
3Y Avg
-110.96%
5Y Avg
-102.03%
Market Cap
$473.57M
Return on Invested Capital (ROIC)
-15.54%
TTM Avg
-22.63%
3Y Avg
-32.48%
5Y Avg
-46.23%
Market Cap
$473.36M
Return on Invested Capital (ROIC)
-13.15%
TTM Avg
-33.80%
3Y Avg
-80.16%
5Y Avg
-71.70%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| 908 Devices Inc. (MASS) | $513.25M | -18.90% | -28.09% | -27.96% | -20.03% |
| Monopar Therapeutics Inc. (MNPR)vs › | $507.55M | -16.89% | -20.74% | -75.97% | -65.59% |
| Altimmune, Inc. (ALT)vs › | $516.46M | -19.47% | -57.88% | -52.57% | -47.02% |
| Immix Biopharma, Inc. (IMMX)vs › | $521.76M | -18.20% | -95.31% | -87.63% | -71.60% |
| Allogene Therapeutics, Inc. (ALLO)vs › | $498.75M | -34.79% | -53.61% | -51.25% | -40.96% |
| Crescent Biopharma, Inc. (CBIO)vs › | $531.34M | -102.59% | -133.31% | -119.78% | -99.25% |
| Delcath Systems, Inc. (DCTH)vs › | $533.01M | -0.81% | -8.59% | -110.96% | -102.03% |
| Evolus, Inc. (EOLS)vs › | $473.57M | -15.54% | -22.63% | -32.48% | -46.23% |
| Bright Minds Biosciences Inc. (DRUG)vs › | $473.36M | -13.15% | -33.80% | -80.16% | -71.70% |
| Arvinas, Inc. (ARVN)vs › | $471.65M | -2.19% | -24.50% | -28.59% | -24.45% |
ROIC
-18.9%
ROE
-27.2%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -18.90% |
| 2026-03-31 | -20.64% |
| 2025-12-31 | -22.35% |
| 2025-09-30 | -34.78% |
| 2025-06-30 | -43.79% |
| 2025-03-31 | -36.44% |
| 2024-12-31 | -44.71% |
| 2024-09-30 | -33.01% |
| 2024-06-30 | -18.47% |
| 2024-03-31 | -21.91% |
| 2023-12-31 | -23.44% |
| 2023-09-30 | -23.31% |
| 2023-06-30 | -21.74% |
| 2023-03-31 | -19.46% |
| 2022-12-31 | -15.84% |
| 2022-09-30 | -12.41% |
| 2022-06-30 | -11.53% |
| 2022-03-31 | -10.85% |
| 2021-12-31 | -8.97% |
| 2021-09-30 | -14.64% |
| 2021-06-30 | -11.88% |
| 2021-03-31 | -5.45% |
| 2020-12-31 | -3.45% |
| 2020-09-30 | -6.48% |
| 2020-06-30 | -15.36% |
| 2019-12-31 | -38.76% |
